These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 27401250)

  • 21. SIX1 promotes tumor lymphangiogenesis by coordinating TGFβ signals that increase expression of VEGF-C.
    Liu D; Li L; Zhang XX; Wan DY; Xi BX; Hu Z; Ding WC; Zhu D; Wang XL; Wang W; Feng ZH; Wang H; Ma D; Gao QL
    Cancer Res; 2014 Oct; 74(19):5597-607. PubMed ID: 25142796
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lysophosphatidic acid induces lymphangiogenesis and IL-8 production in vitro in human lymphatic endothelial cells.
    Mu H; Calderone TL; Davies MA; Prieto VG; Wang H; Mills GB; Bar-Eli M; Gershenwald JE
    Am J Pathol; 2012 May; 180(5):2170-81. PubMed ID: 22465753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.
    Kim KS; Park JI; Oh N; Cho HJ; Park JH; Park KS
    Sci Rep; 2019 Jun; 9(1):8418. PubMed ID: 31182803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma.
    Cadamuro M; Brivio S; Mertens J; Vismara M; Moncsek A; Milani C; Fingas C; Cristina Malerba M; Nardo G; Dall'Olmo L; Milani E; Mariotti V; Stecca T; Massani M; Spirli C; Fiorotto R; Indraccolo S; Strazzabosco M; Fabris L
    J Hepatol; 2019 Apr; 70(4):700-709. PubMed ID: 30553841
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Phomaketide A Inhibits Lymphangiogenesis in Human Lymphatic Endothelial Cells.
    Tai HC; Lee TH; Tang CH; Chen LP; Chen WC; Lee MS; Chen PC; Lin CY; Chi CW; Chen YJ; Lai CT; Chen SS; Liao KW; Lee CH; Wang SW
    Mar Drugs; 2019 Apr; 17(4):. PubMed ID: 30959907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanisms of Tumor-Induced Lymphovascular Niche Formation in Draining Lymph Nodes.
    Commerford CD; Dieterich LC; He Y; Hell T; Montoya-Zegarra JA; Noerrelykke SF; Russo E; Röcken M; Detmar M
    Cell Rep; 2018 Dec; 25(13):3554-3563.e4. PubMed ID: 30590031
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Laminin γ2-enriched extracellular vesicles of oral squamous cell carcinoma cells enhance in vitro lymphangiogenesis via integrin α3-dependent uptake by lymphatic endothelial cells.
    Wang SH; Liou GG; Liu SH; Chang JS; Hsiao JR; Yen YC; Chen YL; Wu WL; Chang JY; Chen YW
    Int J Cancer; 2019 Jun; 144(11):2795-2810. PubMed ID: 30485433
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Docetaxel facilitates lymphatic-tumor crosstalk to promote lymphangiogenesis and cancer progression.
    Harris AR; Perez MJ; Munson JM
    BMC Cancer; 2018 Jul; 18(1):718. PubMed ID: 29976154
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Extracellular Hsp90α Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
    Hou Q; Chen S; An Q; Li B; Fu Y; Luo Y
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299365
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lysyl Oxidase-Like Protein 2 Promotes Tumor Lymphangiogenesis and Lymph Node Metastasis in Breast Cancer.
    Wang C; Xu S; Tian Y; Ju A; Hou Q; Liu J; Fu Y; Luo Y
    Neoplasia; 2019 Apr; 21(4):413-427. PubMed ID: 30925417
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibition of TGFBIp expression reduces lymphangiogenesis and tumor metastasis.
    Maeng YS; Aguilar B; Choi SI; Kim EK
    Oncogene; 2016 Jan; 35(2):196-205. PubMed ID: 25772247
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV-1 matrix protein p17 promotes lymphangiogenesis and activates the endothelin-1/endothelin B receptor axis.
    Caccuri F; Rueckert C; Giagulli C; Schulze K; Basta D; Zicari S; Marsico S; Cervi E; Fiorentini S; Slevin M; Guzman CA; Caruso A
    Arterioscler Thromb Vasc Biol; 2014 Apr; 34(4):846-56. PubMed ID: 24482377
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Suppression of lymphangiogenesis by soluble vascular endothelial growth factor receptor-2 in a mouse lung cancer model.
    Maehana S; Nakamura M; Ogawa F; Imai R; Murakami R; Kojima F; Majima M; Kitasato H
    Biomed Pharmacother; 2016 Dec; 84():660-665. PubMed ID: 27697638
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor metastasis and the lymphatic vasculature.
    Sleeman JP; Thiele W
    Int J Cancer; 2009 Dec; 125(12):2747-56. PubMed ID: 19569051
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-induced activation of lymphatic endothelial cells via vascular endothelial growth factor receptor-2 is critical for prostate cancer lymphatic metastasis.
    Zeng Y; Opeskin K; Goad J; Williams ED
    Cancer Res; 2006 Oct; 66(19):9566-75. PubMed ID: 17018613
    [TBL] [Abstract][Full Text] [Related]  

  • 36. S1PR1 regulates the quiescence of lymphatic vessels by inhibiting laminar shear stress-dependent VEGF-C signaling.
    Geng X; Yanagida K; Akwii RG; Choi D; Chen L; Ho Y; Cha B; Mahamud MR; Berman de Ruiz K; Ichise H; Chen H; Wythe JD; Mikelis CM; Hla T; Srinivasan RS
    JCI Insight; 2020 Jul; 5(14):. PubMed ID: 32544090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Paralemmin-1 is expressed in lymphatic endothelial cells and modulates cell migration, cell maturation and tumor lymphangiogenesis.
    Albrecht I; Bieri R; Leu A; Granacher P; Hagmann J; Kilimann MW; Christofori G
    Angiogenesis; 2013 Oct; 16(4):795-807. PubMed ID: 23709172
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transcriptional profiling of breast cancer-associated lymphatic vessels reveals VCAM-1 as regulator of lymphatic invasion and permeability.
    Dieterich LC; Kapaklikaya K; Cetintas T; Proulx ST; Commerford CD; Ikenberg K; Bachmann SB; Scholl J; Detmar M
    Int J Cancer; 2019 Nov; 145(10):2804-2815. PubMed ID: 31344266
    [TBL] [Abstract][Full Text] [Related]  

  • 39. c-Myc promotes lymphatic metastasis of pancreatic neuroendocrine tumor through VEGFC upregulation.
    Chang TM; Chu PY; Hung WC; Shan YS; Lin HY; Huang KW; Chang JS; Chen LT; Tsai HJ
    Cancer Sci; 2021 Jan; 112(1):243-253. PubMed ID: 33128283
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathway-related molecules of VEGFC/D-VEGFR3/NRP2 axis in tumor lymphangiogenesis and lymphatic metastasis.
    Wang J; Huang Y; Zhang J; Wei Y; Mahoud S; Bakheet AM; Wang L; Zhou S; Tang J
    Clin Chim Acta; 2016 Oct; 461():165-71. PubMed ID: 27527412
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.